1.Pharmaceutical Care for Anti-infective Therapy in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
Hua LIU ; Lifen LI ; Changjie CAI ; Jiahui LIN ; Jie PAN ; Yanzhe XIA
Herald of Medicine 2025;44(9):1508-1511
Objective To explore the pharmaceutical care clinical pharmacists provide for anti-infective therapy in patients undergoing continuous renal replacement therapy(CRRT)after lung transplantation.Methods The clinical pharmacist utilized a limited sampling strategy and participated in the entire anti-infective treatment process for an adult lung transplant recipient based on pharmacokinetic monitoring results.The CRRT duration was flexibly adjusted,the dosing regimen was optimized,and adverse drug reactions were monitored.Result The clinical pharmacist assisted the physician in optimizing the polymyxin B anti-infective therapy post-transplantation,leading to successful infection control and patient discharge.Conclusion Clinical pharmacists can conduct real-time drug concentration monitoring in lung transplant patients based on pharmacokinetic characteristics,develop individualized dosing regimens,and improve medication safety and efficacy during anti-infective therapy.
2.Pharmaceutical Care for Anti-infective Therapy in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy
Hua LIU ; Lifen LI ; Changjie CAI ; Jiahui LIN ; Jie PAN ; Yanzhe XIA
Herald of Medicine 2025;44(9):1508-1511
Objective To explore the pharmaceutical care clinical pharmacists provide for anti-infective therapy in patients undergoing continuous renal replacement therapy(CRRT)after lung transplantation.Methods The clinical pharmacist utilized a limited sampling strategy and participated in the entire anti-infective treatment process for an adult lung transplant recipient based on pharmacokinetic monitoring results.The CRRT duration was flexibly adjusted,the dosing regimen was optimized,and adverse drug reactions were monitored.Result The clinical pharmacist assisted the physician in optimizing the polymyxin B anti-infective therapy post-transplantation,leading to successful infection control and patient discharge.Conclusion Clinical pharmacists can conduct real-time drug concentration monitoring in lung transplant patients based on pharmacokinetic characteristics,develop individualized dosing regimens,and improve medication safety and efficacy during anti-infective therapy.
3.Perioperative coagulation management in liver transplantation: a theoretical and practical exploration
Yao TANG ; Jiaxian LYU ; Changjie CAI
Chinese Journal of Hematology 2024;45(S1):26-30
Objective:To investigate the characteristics of changes in coagulation function in different pathophysiological states during the preoperative, intraoperative, and postoperative phases of liver transplantation, along with its corresponding monitoring and clinical management strategies, and to provide our center's experience to other medical institutions.Methods:By reporting and analyzing the diagnosis and treatment process of a patient with secondary liver failure after hepatectomy in the perioperative period of liver transplantation, we summarize the characteristics of coagulation function in the perioperative period of liver transplantation as well as the management strategies, taking into account the consensus of relevant domestic and international guidelines.Results:In this case report, the pathophysiologic mechanisms of the different stages of perioperative liver transplantation differed significantly, and the corresponding changes in coagulation function were complex and difficult to measure. The coagulation characteristics of the perioperative stages can be summarized as preoperative platelet and coagulation factor deficiencies, intraoperative hypocoagulation and hyperfibrinolysis, postoperative incomplete recovery of coagulation function, and the coexistence of the risk of hemorrhage and thrombosis throughout the entire process, which should be treated with goal-oriented transfusion of blood products, anticoagulation, and antifibrinolysis, according to dynamic changes of the coagulation system, platelet counts, thrombus-related test indexes, and the overall function of the coagulation system such as the thromboelastogram. Under the premise of dynamic monitoring of relevant indicators, appropriate and moderate treatment should be given to maintain the relative homeostasis among the three systems of coagulation promotion, anticoagulation, and fibrinolysis, which not only avoids bleeding of vital organs caused by hypocoagulation, but also reduces the risk of perioperative thrombotic complications, and accurate monitoring and individualized treatment can improve the prognosis of the patients.Conclusion:Coagulation management in the perioperative period of liver transplantation is complex and variable, requiring enhanced monitoring and active and effective interventions. This study provides an important reference for the perioperative diagnosis and treatment of patients with end-stage liver disease and summarizes the effective management experience.
4.Perioperative coagulation management in liver transplantation: a theoretical and practical exploration
Yao TANG ; Jiaxian LYU ; Changjie CAI
Chinese Journal of Hematology 2024;45(S1):26-30
Objective:To investigate the characteristics of changes in coagulation function in different pathophysiological states during the preoperative, intraoperative, and postoperative phases of liver transplantation, along with its corresponding monitoring and clinical management strategies, and to provide our center's experience to other medical institutions.Methods:By reporting and analyzing the diagnosis and treatment process of a patient with secondary liver failure after hepatectomy in the perioperative period of liver transplantation, we summarize the characteristics of coagulation function in the perioperative period of liver transplantation as well as the management strategies, taking into account the consensus of relevant domestic and international guidelines.Results:In this case report, the pathophysiologic mechanisms of the different stages of perioperative liver transplantation differed significantly, and the corresponding changes in coagulation function were complex and difficult to measure. The coagulation characteristics of the perioperative stages can be summarized as preoperative platelet and coagulation factor deficiencies, intraoperative hypocoagulation and hyperfibrinolysis, postoperative incomplete recovery of coagulation function, and the coexistence of the risk of hemorrhage and thrombosis throughout the entire process, which should be treated with goal-oriented transfusion of blood products, anticoagulation, and antifibrinolysis, according to dynamic changes of the coagulation system, platelet counts, thrombus-related test indexes, and the overall function of the coagulation system such as the thromboelastogram. Under the premise of dynamic monitoring of relevant indicators, appropriate and moderate treatment should be given to maintain the relative homeostasis among the three systems of coagulation promotion, anticoagulation, and fibrinolysis, which not only avoids bleeding of vital organs caused by hypocoagulation, but also reduces the risk of perioperative thrombotic complications, and accurate monitoring and individualized treatment can improve the prognosis of the patients.Conclusion:Coagulation management in the perioperative period of liver transplantation is complex and variable, requiring enhanced monitoring and active and effective interventions. This study provides an important reference for the perioperative diagnosis and treatment of patients with end-stage liver disease and summarizes the effective management experience.
5.Preliminary study on expression profiles of plasma circulating microRNAs in patients with sepsis and healthy control people
Jiyou YAO ; Jiaxian LV ; Li TONG ; Xiaoguang HU ; Lu CAO ; Yanping ZHU ; hong Jing XU ; Changjie CAI
The Journal of Practical Medicine 2017;33(24):4024-4028
Objective To identify the circulating miRNAs which can be used to evaluate the diagnosis and prognosis of sepsis by microarray and quantitative real-time PCR,and to predict target genes of miR-519c-5p by bioinformatics analysis. Methods Three sepsis patients,3 septic shock patients and 3 normal controls were enrolled in this study. Plasma RNA was extracted,and was used for hybridized by miRCURY LNATMmicroRNA Array.The signals were scanned and used to conduct differential expression profilings and cluster analysis.Further-more,we performed qRT-PCR to confirm the expression of miRNAs chosen from microarray screening. We used the miRanda and Targetscan databases to predict target genes of the concerned miRNAs and used KEGG database to analyze the related pathways. Results Fifty-seven and 11 miRNAs were observed significantly upregulated in sepsis and septic shock patients,respectively(fold change≥2.0;P<0.05).qRT-PCR results showed that miR-519c-5p was significantly upregulated in patients with sepsis or patients with septic shock compared with the healthy normal controls(P<0.05).Twenty-nine target genes of miR-519c-5p were predicted by the bioinformatics analysis,and 7 potential target genes participate in the sepsis-related pathways.MiR-519c-5p might be a potential positive regulator for the critical cell cycle control gene of MAP2K4,contributing to the vascular endothelial cells apoptosis via MAPK signaling pathway. Conclusions We demonstrated that the plasma level of miR-519c-5p can be used for the diagnosis of sepsis and miR-519c-5p may be a potential therapeutic target for sepsis.
6.Bacteriological analysis and treatment strategy in patients with biliary sepsis
Ye ZHANG ; Li TONG ; Zhaoxia TANG ; Jiyou YAO ; Yanping ZHU ; Xiaoguang HU ; Lifen LI ; Shunwei HUANG ; Changjie CAI
Chinese Journal of Hepatobiliary Surgery 2017;23(4):235-238
Objectives To access the bacteriology in patients with sepsis due to biliary tract infection to provide a basis for empirical selection of proper antibiotic treatment.Methods This is a single-center retrospective study on 214 patients with biliary tract infection admitted from August 2014 to July 2016 to the surgical intensive care units (ICU) of The First Affiliated Hospital of Sun Yat-sen University.To study the demographic information,sequential organ failure assessment (SOFA),usage of antibiotics before ICU and duration of ICU were analyzed.Bile,peritoneal drainage and blood samples were collected.Results 47 septic shock patients and 25 septic patients due to biliary tract infection were enrolled in the trial.The two groups (the shock group vs.the sepsis group) had a significant difference in the duration of ICU stay [(6.4 ± 4.6) d vs.(2.3 ± 1.8) d,P < 0.05].48 strains of pathogens were isolated from the bile samples.The major pathogens were Escherichia coli (E.coli) (n =23,47.9%),Enterococcus faecalis (n =8,16.7%) and Enterococcus faecium (n =2,4.2%).80 strains of pathogens were isolated from the peritoneal drainage culture samples.E.coli,pseudomonas aeruginosa,and Klebsiella pneumoniae ranked the top 3 species,accounting for 26.3%,11.3% and 7.5%,respectively.The sensitivity of E.coli isolated from bile to amikacin,imipenem and panipenem were all over 90.0%.Conclusions E.coli was the principal gram-negative bacterium in biliary infection induced sepsis.Early administration of carbapenemes may reduce the occurrence of septic shock in these patients.
7.High risk factors of blood infection in voluntary donors in China: A single-centre retrospective study
Li TONG ; Donghua ZHENG ; Yanping ZHU ; Xiaoguang HU ; Changjie CAI
Chinese Journal of Organ Transplantation 2016;37(12):753-757
Objective To analyze the high risk factors of blood infection in Chinese citizens' organ donation,provide the basic evidence for early protection,increase the success rate of donor distribution,and expand the Chinese organ donation pool.Methods A retrospective study was performed on 70 cases of donation recruited during October 2014 to January 2016.The incidence of blood infection in these donors was analyzed.The univariate analysis and multivariate logistic regression analysis were used to find out the high risk factors influencing the donor blood infection.Finally,the donor blood infection assessment model and the receiver operating characteristic (ROC) curve were established to assess the sensitivity and specificity.Results The overall infection rate was 64.3% (45/70).The pulmonary,blood,and urinary tract infection rate was 42.9%,31.4% and 1.4% respectively.The total length of hospital stay (>10 days) (P =0.017),oxygenation index (< 233.5 ± 107.0) (P =0.046),aspartate aminotransferase (>196.9 ± 329.1 U/L) (P =0.044),and valley alanine aminotransferase (>95.0 ± 78.1 U/L) (P =0.026) were four risk factors for predicting the donor blood infection.The multivariate logistic regression analysis revealed that the total length of stay >10 days along with the donors' oxygenation index (<233.5 ± 107.0) was independent risk factor for predicting the blood infection.The donor blood infection model was:0.193 + 1.753 hospital stay (>10 days)-0.007 oxygenation index.The sensitivity and specificity were 0.682 and 0.75 (P <0.001) respectively.Conclusion For a long-term stay in ICU,the rate of blood infection for donors was much higher,at this time,the most effective antibiotics should be chosen.Besides,improving donor oxygenation index and liver function can reduce the incidence of infection.
8.Comparison of antiviral efficacy and economics between lamivudine and entecavir in patients with low preoperative HBV replication after liver transplantation
The Journal of Practical Medicine 2015;(12):2020-2023
Objective To compare the antiviral efficacy and economics between lamivudine and entecavir in patients with low preoperative HBV replication after liver transplantation. Methods Liver transplantation patients from 2006 July to 2013 July were selected for being studied prospectively. Statistically evaluated between entecavir and lamivudine efficacy by the analysis of postoperative follow-up of seroconversion and HBV reinfection. Results The cumulative overcast rate of entecavir group was 98.04% one month after transplatation. And 3 of 51 cases were reinfected with average turn time of 9.73 days. Meanwhile , the cumulative overcast rate of Lamivudine group was 100% and 3 of 26 cases were reinfected with average turn time of 5.11 days. There are no statistical differences between the two groups accumulation rate , reinfection rates , as well as cumulative infection rates. Conclusion In the cases of low hepatitis B virus replication before liver transplantation, Entecavir and Lamivudine have the similar effect of preventing HBV reinfection after operation. Compared with the cost of Entecavir group, Lamivudine is more economy.
9.The value of passive leg raising test in predicting fluid responsiveness in patients with sepsis-induced cardiac dysfunction
Xiang SI ; Muyun HUANG ; Juan CHEN ; Bin OUYANG ; Minying CHEN ; Changjie CAI ; Jianfeng WU ; Zimeng LIU ; Yongjun LIU ; Shunwei HUANG ; Lifen LI ; Xiangdong GUAN
Chinese Critical Care Medicine 2015;(9):729-734
ObjectiveTo assess the value of passive leg raising (PLR) test in predicting fluid responsiveness in patients with sepsis-induced cardiac dysfunction.Methods A prospective observational cohort study was conducted. Thirty-eight patients under mechanical ventilation suffering from sepsis-induced cardiac dysfunction admitted to Department of Surgical Intensive Care Unit of First Affiliated Hospital of Sun Yat-Sen University from September 2013 to July 2014 were enrolled. The patients were studied in four phases: before PLR (semi-recumbent position with the trunk in 45°), PLR (the lower limbs were raised to a 45° angle while the trunk was in a supine position), before volume expansion (VE, return to the semi-recumbent position), and VE with infusing of 250 mL 5% albumin within 30 minutes. Hemodynamic parameters were recorded in every phase. The patients were classified into two groups according to their response to VE: responders (at least a 15% increase in stroke volume,ΔSVVE≥15%), and non-responders. The correlations among all changes in hemodynamic parameters were analyzed by linear correlation analysis, and the receiver operating characteristic curve (ROC) was plotted to assess the value of hemodynamic parameters before and after PLR in predicting fluid responsiveness.Results Of 38 patients, 25 patients were responders, and 13 non-responders. There was no significant difference in the baseline and hemodynamic parameters at semi-recumbent position between the two groups. The changes in SV and cardiac output (CO) after PLR (ΔSVPLR andΔCOPLR) were significantly higher in responders than those of non-responders [ΔSVPLR: (14.7±5.7)%vs. (6.4±5.3)%,t = 4.304,P = 0.000;ΔCOPLR: (11.2±7.5)% vs. (3.4±2.3)%,t = 3.454,P = 0.001], but there was no significant difference in the changes in systolic blood pressure, mean arterial pressure, pulse pressure, and heart rate after PLR (ΔSBPPLR,ΔMAPPLR,ΔPPPLR andΔHRPLR) between two groups.ΔSVVE in responders was significantly higher than that of the non-responders [(20.8±5.5) % vs. (5.0±3.7) %,t = 8.347,P = 0.000]. It was shown by correlation analysis thatΔSVPLR was positively correlated withΔSVVE (r = 0.593,P = 0.000),ΔCOPLR was positively correlated withΔSVVE (r = 0.494,P = 0.002). The area under ROC curve (AUC) ofΔSVPLR≥8.1% for predicting fluid responsiveness was 0.860±0.062 (P = 0.000), with sensitivity of 92.0% and specificity of 70.0%; the AUC ofΔCOPLR≥5.6% for predicting fluid responsiveness was 0.840±0.070 (P = 0.000), with sensitivity of 84.0%and specificity of 76.9%; the AUC ofΔMAPPLR≥6.9% for predicting fluid responsiveness was 0.662±0.089, with sensitivity of 68.0% and specificity of 76.9%; the AUC ofΔSBPPLR≥6.4% for predicting fluid responsiveness was 0.628±0.098, with sensitivity of 76.0% and specificity of 61.5%; the AUC ofΔPPPLR≥6.2% for predicting fluid responsiveness was 0.502±0.094, with sensitivity of 56.0% and specificity of 53.8%; the AUC ofΔHRPLR≥-1.7%for predicting fluid responsiveness was 0.457±0.100, with sensitivity of 56.0% and specificity of 46.2%.Conclusion In patients with sepsis-induced cardiac dysfunction, changes in SV and CO induced by PLR are accurate indices for predicting fluid responsiveness, but the changes in HR, MAP, SBP and PP cannot predict the fluid responsiveness.
10.Protective effect of myeloid-derived suppressor cells in mice with sepsis
Xiaoguang HU ; Li TONG ; Yongjun LIU ; Lu CAO ; Yanping ZHU ; Xiangdong GUAN ; Changjie CAI
The Journal of Practical Medicine 2014;(11):1690-1692
Objective To investigate whether myeloid-derived suppressor cells (MDSCs) have a protective effect in septic mice. Methods The model of caecal ligation and puncture (CLP) was performed to induce polymicrobial sepsis in mice. The changes of MDSCs in spleens at different times after operation were studied. In order to observe the influence of MDSCs on the inflammatory factors and survival of septic mice, MDSCs were injected into the peritoneal cavities of mice after CLP. Results MDSCs accumulated in spleens of septic mice progressively. MDSCs could increase anti-inflammatory cytokine production, decrease the level of inflammatory factors, and improve the survival rate of mice with sepsis. Conclusion MDSCs can attenuate the inflammation and improve the survival rate of mice with sepsis, suggesting that intraperitoneal injection of MDSCs may provide a new direction for the treatment of sepsis.

Result Analysis
Print
Save
E-mail